Drugs /

yttrium y 90 resin microspheres

Back to Drugs List

Overview

Generic Name(s):
yttrium y 90 resin microspheres
Trade Name(s):
Sir-Spheres
NCI Definition [1]:
An injectable formulation of the radioisotope yttrium Y 90 encapsulated in resin microspheres with potential antineoplastic activity. When injected into arterial vasculature supplying the tumor, yttrium Y 90 resin microspheres occlude tumor blood vessels and selectively deliver a cytotoxic dose of beta emitting yttrium Y 90 to the tumor site, which may result in tumor cell death and tumor regression.

Clinical Trials

View Clinical Trials for yttrium y 90 resin microspheres

Yttrium y 90 resin microspheres has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating yttrium y 90 resin microspheres, 1 is phase 1/phase 2 (1 open).

Uveal melanoma is the most common disease being investigated in yttrium y 90 resin microspheres clinical trials [2].

Drug Details

Synonyms [2]:
SIR-Spheres, yttrium y 90 resin microspheres
NCIT ID [1]:
C64539

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.